. The company’s pipeline features 4 clinical-stage therapies. Its most advanced drug applicant is ROS1 inhibitor taletrectinib for treating lung cancer. Nuvation is finishing two stage 2 pivotal scientific tests on taletrectinib.Below’s your disclaimer: There are loads of factors to take into consideration when trading penny stocks. The markets